{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T11:07:45Z","timestamp":1778843265852,"version":"3.51.4"},"reference-count":192,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"abstract":"<jats:p>\n                    Adequate policies to achieve universal access to high-quality diagnostics and therapeutics in the challenge represented by Trypanosomatidae-borne diseases remain essential to command surveillance as a successful tool and a way to delay the unavoidable surge of resistance toward the currently used drugs. In the case of leishmaniasis, even for uncomplicated cutaneous leishmaniasis, most patients in endemic regions are treated with systemic therapies due to reasons such as local protocol misalignment, limited access to new technologies, and lesions being located in anatomical areas other than the face or near the joints. These facts constitute a challenge for rural patients, especially in endemic areas, with limited access to medical facilities and compromising treatment adherence and clinical follow-up, thus increasing the evolution of treatment failure. In pharmacological-pharmaceutical terms, this means that there is an urgent need to minimize the rate of drug attrition and maximize the potential for success. For example,\n                    <jats:italic>in silico<\/jats:italic>\n                    computational chemistry data with no inclusion of\n                    <jats:italic>in vitro<\/jats:italic>\n                    or experimental data can produce more difficulties than advantages. The main reason is that the disparity between computational estimates and\n                    <jats:italic>in vitro<\/jats:italic>\n                    \/\n                    <jats:italic>in vivo<\/jats:italic>\n                    studies may result in data that cycle within a never-ending loop, causing, despite enormous efforts, no great advance in producing novel compounds against parasites to treat the diseases. Thus, while considerable progress has been made in diagnosis, prevention, and treatment of Trypanosomatidae-transmitted diseases, significant challenges remain in the effort to develop new drugs in a One Health, One World environment. The consequence is high failure rates worldwide, a challenge we should all overcome to improve the outcome for a new drug portfolio.\n                  <\/jats:p>","DOI":"10.3389\/fchem.2026.1815438","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:15:20Z","timestamp":1778840120000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Trypanosomatid parasites, translational research in a One Health, One World environment"],"prefix":"10.3389","volume":"14","author":[{"given":"Alicia","family":"Ponte-Sucre","sequence":"first","affiliation":[{"name":"Department of Physiological Sciences, Chair of Human Physiology, Laboratory of Molecular Physiology, Institute of Experimental Medicine, Luis Razetti School, Universidad Central de Venezuela","place":["Caracas, Venezuela"]},{"name":"Medical Mission Institute","place":["W\u00fcrzburg, Germany"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e369","DOI":"10.1097\/INF.0000000000004876","article-title":"A perspective on human leishmaniasis and novel therapeutic methods for diagnosis, prevention and treatment","volume":"44","author":"Abbasi","year":"2025","journal-title":"Pediatr. Infect. Dis. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3389\/fimmu.2019.00492","article-title":"Leishmania-host Interactions-An epigenetic paradigm","volume":"10","author":"Afrin","year":"2019","journal-title":"Front. Immunol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.4103\/ijcm.IJCM_398_19","article-title":"One health approach to address zoonotic diseases","volume":"45","author":"Aggarwal","year":"2020","journal-title":"Indian J. Community Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0004349","DOI":"10.1371\/journal.pntd.0004349","article-title":"A historical overview of the classification, evolution, and dispersion of leishmania parasites and sandflies","volume":"10","author":"Akhoundi","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2016.11.012","article-title":"Leishmania infections: molecular targets and diagnosis","volume":"57","author":"Akhoundi","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"103611","DOI":"10.1016\/j.drudis.2023.103611","article-title":"Strategic trends of pharmaceutical companies: a growth model through regional focus and inter-regional alliances","volume":"28","author":"Akinori","year":"2023","journal-title":"Drug Discov. Today"},{"key":"B7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1126\/science.1169464","article-title":"Demonstration of genetic exchange during cyclical development of leishmania in the sand fly vector","volume":"324","author":"Akopyants","year":"2009","journal-title":"Science"},{"key":"B8","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/microorganisms12010043","article-title":"Antileishmanial and antitrypanosomes drugs for the current century","volume":"12","author":"Alunda","year":"2024","journal-title":"Microorganisms"},{"key":"B9","doi-asserted-by":"publisher","first-page":"102942","DOI":"10.1016\/j.parint.2024.102942","article-title":"Half a century of Japanese research on two neglected tropical diseases (trypanosomiasis and leishmaniasis): overseas scientific cooperation","volume":"3","author":"Alunda","year":"2024","journal-title":"Parasitol. Int."},{"key":"B10","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.pt.2006.09.004","article-title":"Leishmaniasis and poverty","volume":"22","author":"Alvar","year":"2006","journal-title":"Trends Parasitol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pt.2012.12.005","article-title":"Drug resistance in African trypanosomiasis: the melarsoprol and pentamidine story","volume":"29","author":"Baker","year":"2013","journal-title":"Trends Parasitol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0015323","DOI":"10.1128\/cmr.00153-23","article-title":"Transforming the chemotherapy of human African trypanosomiasis","volume":"38","author":"Barrett","year":"2025","journal-title":"Clin. Microbiol. Rev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41579-019-0238-x","article-title":"Protozoan persister-like cells and drug treatment failure","volume":"17","author":"Barrett","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e1010537","DOI":"10.1371\/journal.ppat.1010537","article-title":"One health: a new definition for a sustainable and healthy future","volume":"18","author":"Behravesh","year":"2022","journal-title":"PLoS Pathog."},{"key":"B15","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.1021\/acsomega.3c09400","article-title":"Genomic insight of leishmania parasite: in-depth review of drug resistance mechanisms and genetic mutations","volume":"9","author":"Bharadava","year":"2024","journal-title":"ACS Omega"},{"key":"B16","doi-asserted-by":"crossref","unstructured":"Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting leishmania MAP kinases\n          \n          122844\n          \n            \n              Bhattacharjee\n              A.\n            \n            \n              Bagchi\n              A.\n            \n            \n              Sarkar\n              S.\n            \n            \n              Bawali\n              S.\n            \n            \n              Bhattacharya\n              A.\n            \n            \n              Biswas\n              A.\n            \n          \n          10.1016\/j.lfs.2024.122844\n          Life Sci\n          351\n          2024","DOI":"10.1016\/j.lfs.2024.122844"},{"key":"B17","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/genes11070722","article-title":"Of drugs and trypanosomatids: new tools and knowledge to reduce bottlenecks in drug discovery","volume":"11","author":"Bhattacharya","year":"2020","journal-title":"Genes"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1573618","DOI":"10.3389\/fmolb.2025.1573618","article-title":"Unravelling drug resistance in leishmaniasis: genomic adaptations and emerging therapies","volume":"12","author":"Bhusal","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"874345","DOI":"10.1155\/2014\/874345","article-title":"Zoonoses and one health: a review of the literature","volume":"2014","author":"Bidaisee","year":"2014","journal-title":"J. Parasitol. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/genes11010004","article-title":"Trans-atlantic spill over: deconstructing the ecological adaptation of Leishmania infantum in the americas","volume":"11","author":"Boit\u00e9","year":"2019","journal-title":"Genes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/RRTM.S24751","article-title":"The detection and treatment of human African trypanosomiasis","volume":"3","author":"Bouteille","year":"2012","journal-title":"Res. Rep. Trop. Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/s0304-4017(98)00146-0","article-title":"Trypanosoma evansi and T. equiperdum: distribution, biology, treatment and phylogenetic relationship (a review)","volume":"79","author":"Brun","year":"1998","journal-title":"Vet. Parasitol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0099524","DOI":"10.1128\/mbio.00995-24","article-title":"Genomic and epidemiological evidence for the emergence of a L. infantum\/L. donovani hybrid with unusual epidemiology in northern Italy","volume":"15","author":"Bruno","year":"2024","journal-title":"mBio"},{"key":"B24","article-title":"Institute of medicine (US) board on international health","volume-title":"Global health in transition: a synthesis: perspectives from international organizations","author":"Bryant","year":"1996"},{"key":"B25","doi-asserted-by":"publisher","first-page":"eabb7656","DOI":"10.1126\/scitranslmed.abb7656","article-title":"A modified drug regimen clears active and dormant trypanosomes in mouse models of chagas disease","volume":"12","author":"Bustamante","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/tbed.12145","article-title":"The components of 'One World - one Health\u2019 approach","volume":"60","author":"Calistri","year":"2013","journal-title":"Transbound. Emerg. Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/ilar\/ilw019","article-title":"J.L. in vivo imaging in pharmaceutical development and its impact on the 3Rs","volume":"57","author":"Campbell","year":"2016","journal-title":"ILAR J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1111\/j.1537-2995.2012.03581.x","article-title":"The United States Trypanosoma cruzi infection study: evidence for vector-borne transmission of the parasite that causes chagas disease among United States blood donors","volume":"52","author":"Cantey","year":"2012","journal-title":"Transfusion"},{"key":"B29","unstructured":"About one health\n          \n          \n          2025"},{"key":"B30","doi-asserted-by":"publisher","first-page":"165689","DOI":"10.1016\/j.bbadis.2020.165689","article-title":"Chagas disease: historic perspective","volume":"1866","author":"Chao","year":"2020","journal-title":"Biochim. Biophys. Acta (BBA). Mol. Basis Dis."},{"key":"B31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14411\/fp.2008.010","article-title":"A diagnostic assay based on variable intergenic region distinguishes between Leishmania donovani and Leishmania infantum","volume":"55","author":"Chocholov\u00e1","year":"2008","journal-title":"Folia Parasitol. (Praha)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.pt.2005.05.010","article-title":"Trypanosoma equiperdum: master of disguise or historical mistake?","volume":"21","author":"Claes","year":"2005","journal-title":"Trends Parasitol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1017\/S0031182011001909","article-title":"In vitro and in vivo behaviour of sympatric leishmania (V.) braziliensis, L. (V.) peruviana and their hybrids","volume":"139","author":"Cortes","year":"2012","journal-title":"Parasitology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/tropicalmed7040054","article-title":"Immune responses in leishmaniasis: an overview","volume":"7","author":"Costa-da-Silva","year":"2022","journal-title":"Trop. Med. Infect. Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1590\/s0074-02762009000400002","article-title":"Present situation and new strategies for chagas disease chemotherapy: a proposal","volume":"104","author":"Coura","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1590\/S0074-0276200200010000","article-title":"A critical review on chagas disease chemotherapy","volume":"97","author":"Coura","year":"2002","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B37","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.pt.2003.09.008","article-title":"Leishmaniasis-current chemotherapy and recent advances in the search for novel drugs","volume":"19","author":"Croft","year":"2003","journal-title":"Trends Parasitol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1172\/JCI29999","article-title":"Drug discovery in jeopardy","volume":"116","author":"Cuatrecasas","year":"2006","journal-title":"J. Clin. Investig."},{"key":"B39","doi-asserted-by":"publisher","first-page":"100881","DOI":"10.1016\/j.lana.2024.100881","article-title":"The epidemiology of chagas disease in the americas","volume":"37","author":"Cucunub\u00e1","year":"2024","journal-title":"Lancet Reg. Health Am."},{"key":"B40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.vetpar.2003.10.015","article-title":"Mechanical transmission of Trypanosoma vivax in cattle by the African tabanid Atylotus fuscipes","volume":"119","author":"Desquesnes","year":"2004","journal-title":"Vet. Parasitol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.vetpar.2009.03.033","article-title":"Development and application of an antibody-ELISA to follow up a Trypanosoma evansi outbreak in a dromedary camel herd in France","volume":"162","author":"Desquesnes","year":"2008","journal-title":"Vet. Parasitol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijpara.2008.07.004","article-title":"Development of a mathematical model for mechanical transmission of trypanosomes and other pathogens of cattle transmitted by tabanids","volume":"39","author":"Desquesnes","year":"2009","journal-title":"Int. J. Parasitol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1574-6968.2012.02607.x","article-title":"Effects of miltefosine on the proliferation, ultrastructure, and phospholipid composition of Angomonas deanei, a trypanosomatid protozoan that harbors a symbiotic bacterium","volume":"333","author":"de Freitas-Junior","year":"2012","journal-title":"FEMS Microbiol. Lett."},{"key":"B43","doi-asserted-by":"publisher","first-page":"194176","DOI":"10.1155\/2013\/194176","article-title":"Trypanosoma evansi and surra: a review and perspectives on origin, history, distribution, taxonomy, morphology, hosts, and pathogenic effects","volume":"2013","author":"Desquesnes","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"B139","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1128\/AAC.02398-12","article-title":"Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay","volume":"57","author":"De Rycker","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B110","doi-asserted-by":"publisher","first-page":"815023","DOI":"10.1155\/2015\/815023","article-title":"Advances in development of new treatment for leishmaniasis","volume":"2015","author":"de Menezes","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B124","doi-asserted-by":"publisher","first-page":"e1005296","DOI":"10.1371\/journal.ppat.1005296","article-title":"Amastin knockdown in Leishmania braziliensis affects parasite-macrophage interaction and results in impaired viability of intracellular amastigotes","volume":"11","author":"de Paiva","year":"2015","journal-title":"PLoS Pathog."},{"key":"B178","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","article-title":"Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments","volume":"23","author":"de Vries","year":"2022","journal-title":"Am. J. Clin. Dermatol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41579-022-00777-y","article-title":"H. Anti-trypanosomatid drug discovery: progress and challenges","volume":"21","author":"De Rycker","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.pt.2017.02.005","article-title":"Developing a progressive control pathway for African animal trypanosomosis","volume":"33","author":"Diall","year":"2017","journal-title":"Trends Parasitol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/tropicalmed5010029","article-title":"New drugs for human African trypanosomiasis: a twenty first century success story","volume":"5","author":"Dickie","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"111121","DOI":"10.1016\/j.celrep.2022.111121","article-title":"Leishmania parasites exchange drug-resistance genes through extracellular vesicles","volume":"40","author":"Douanne","year":"2022","journal-title":"Cell Rep."},{"key":"B146","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s13071-019-3323-0","article-title":"Use of miltefosine to treat canine visceral leishmaniasis caused by Leishmania infantum in Brazil","volume":"12","author":"Dos Santos Nogueira","year":"2019","journal-title":"Parasit. Vectors"},{"key":"B47","unstructured":"Fexindazole\n          \n          \n          2018"},{"key":"B48","volume-title":"Acoziborole","year":"2020"},{"key":"B49","unstructured":"Chagas dis\u00e9ase\n          \n          \n          2024"},{"key":"B50","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1590\/0074-02760140446","article-title":"The rising importance of Triatoma rubrofasciata","volume":"110","author":"Dujardin","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B51","doi-asserted-by":"publisher","first-page":"e00599-17","DOI":"10.1128\/mBio.00599-17","article-title":"Modulation of aneuploidy in Leishmania donovani during adaptation to different in vitro and in vivo environments and its impact on gene expression","volume":"8","author":"Dumetz","year":"2017","journal-title":"mBio"},{"key":"B52","doi-asserted-by":"publisher","first-page":"e00548-17","DOI":"10.1128\/mSphere.00548-17","article-title":"Molecular preadaptation to antimony resistance in Leishmania donovani on the Indian subcontinent","volume":"3","author":"Dumetz","year":"2018","journal-title":"mSphere"},{"key":"B53","doi-asserted-by":"publisher","first-page":"104440","DOI":"10.1016\/j.ebiom.2023.104440","article-title":"Leishmania: an urgent need for new treatments","volume":"87","year":"2023","journal-title":"EBioMedicine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.15212\/ZOONOSES-2022-0037","article-title":"One health approach for the control of zoonotic diseases zoonoses","volume":"2","author":"Erkyihun","year":"2022","journal-title":"Zoonoses"},{"key":"B55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1590\/s0036-46651997000200002","article-title":"Immune responses induced by a leishmania (leishmania) amazonensis recombinant antigen in mice and lymphocytes from vaccinated subjects","volume":"39","author":"Fernandes","year":"1997","journal-title":"Rev. Inst. Med. Trop. Sao Paulo."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1021\/acs.molpharmaceut.4c01133","article-title":"Targeted oral fixed-dose combination of amphotericin B-Miltefosine for visceral leishmaniasis","volume":"22","author":"Fern\u00e1ndez-Garc\u00eda","year":"2025","journal-title":"Mol. Pharm."},{"key":"B57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3389\/fbioe.2016.00043","article-title":"Lost in translation: the gap in scientific advancements and clinical application","volume":"4","author":"Fernandez-Moure","year":"2016","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e1013213","DOI":"10.1371\/journal.ppat.1013213","article-title":"At the genetic crossroads of leishmania: emerging hybrids reshaping disease patterns","volume":"21","author":"Ferreira","year":"2025","journal-title":"PLoS Pathog."},{"key":"B59","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3390\/pathogens11050580","article-title":"Experimental hybridization in leishmania: tools for the study of genetic exchange","volume":"11","author":"Ferreira","year":"2022","journal-title":"Pathogens"},{"key":"B60","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrmicro.2016.193","article-title":"Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need","volume":"15","author":"Field","year":"2017","journal-title":"Nat. Rev. Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"e1002855","DOI":"10.1371\/journal.pcbi.1002855","article-title":"Identifying transmission cycles at the human-animal interface: the role of animal reservoirs in maintaining gambiense human African trypanosomiasis","volume":"9","author":"Funk","year":"2013","journal-title":"PLoS Comput. Biol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1017\/S0031182020000645","article-title":"Human African trypanosomiasis: the current situation in endemic regions and the risks for non-endemic regions from imported cases","volume":"147","author":"Gao","year":"2020","journal-title":"Parasitology"},{"key":"B64","doi-asserted-by":"publisher","first-page":"112020","DOI":"10.1016\/j.biopha.2021.112020","article-title":"Advances in the treatment of chagas disease: promising new drugs, plants and targets","volume":"142","author":"Garc\u00eda-Huertas","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Causes of death collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the global burden of disease study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"B66","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/9783527626816.ch1","article-title":"Target identification and mechanism-based screening for anthelmintics: application of veterinary research programs to search for new antiparasitic drugs for human indications","volume-title":"Antiparasitic and antibacterial drug discovery: from molecular targets to drug candidates","author":"Geary","year":"2009"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1017\/S0031182016001268","article-title":"The animal trypanosomiases and their chemotherapy: a review","volume":"143","author":"Giordani","year":"2016","journal-title":"Parasitology"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e2413367121","DOI":"10.1073\/pnas.2413367121","article-title":"One health needs ecology","volume":"121","author":"Gittleman","year":"2024","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e0003820","DOI":"10.1371\/journal.pntd.0003820","article-title":"Ex vivo host and parasite response to antileishmanial drugs and immunomodulators","volume":"9","author":"Gonz\u00e1lez-Fajardo","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"12973","DOI":"10.1038\/s41598-025-96849-z","article-title":"Genomic characterization of leishmania (V.) braziliensis associated with antimony therapeutic failure and variable in vitro tolerance to amphotericin B","volume":"15","author":"Gonz\u00e1lez-Garc\u00eda","year":"2025","journal-title":"Sci. Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"108747","DOI":"10.1016\/j.exppara.2024.108747","article-title":"Compounds with potentialities as novel chemotherapeutic agents in leishmaniasis at preclinical level","volume":"260","author":"Gonz\u00e1lez-Matos","year":"2024","journal-title":"Exp. Parasitol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4269\/ajtmh.19-0931","article-title":"Combination therapy against Indian visceral leishmaniasis with liposomal amphotericin B (FungisomeTM) and short-course miltefosine in comparison to miltefosine monotherapy","volume":"103","author":"Goswami","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"B73","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1377\/hlthaff.2014.1047","article-title":"The roles of patents and research and development incentives in biopharmaceutical innovation","volume":"34","author":"Grabowski","year":"2015","journal-title":"Health Aff. (Millwood)"},{"key":"B74","first-page":"199","article-title":"Human visceral leishmaniasis prevalence by different diagnostic methods in Latin America: a systematic review and meta-analysis","volume":"29","author":"Guti\u00e9rrez-Ocampo","year":"2021","journal-title":"Infez. Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1128\/AAC.05135-11","article-title":"Activation of benznidazole by trypanosomal type I nitroreductases results in glyoxal formation","volume":"56","author":"Hall","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B76","doi-asserted-by":"publisher","first-page":"13088","DOI":"10.1074\/jbc.M111.230847","article-title":"Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites","volume":"286","author":"Hall","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B77","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/1756-3305-6-322","article-title":"Domestic pigs as potential reservoirs of human and animal trypanosomiasis in northern Tanzania","volume":"6","author":"Hamill","year":"2013","journal-title":"Parasites Vectors"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1038\/s42003-024-07278-z","article-title":"Evolutionary genomics of Leishmania braziliensis across the neotropical realm","volume":"7","author":"Heeren","year":"2024","journal-title":"Commun. Biol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1007\/s00436-019-06443-2","article-title":"Need for sustainable approaches in antileishmanial drug discovery","volume":"118","author":"Hendrickx","year":"2018","journal-title":"Parasitol. Res."},{"key":"B80","article-title":"Human african trypanosomiasis (sleeping sickness)","volume-title":"StatPearls","author":"Hollingshead","year":"2024"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e0003895","DOI":"10.1371\/journal.pntd.0003895","article-title":"Eliminating the neglected tropical diseases: translational science and new technologies","volume":"10","author":"Hotez","year":"2016","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B82","unstructured":"Statement at the high-level meeting on universal health coverage\n          \n          \n          2023"},{"key":"B83","doi-asserted-by":"publisher","first-page":"e1008042","DOI":"10.1371\/journal.pgen.1008042","article-title":"Whole genome sequencing of experimental hybrids supports meiosis-like sexual recombination in leishmania","volume":"15","author":"Inbar","year":"2019","journal-title":"PLoS Genet."},{"key":"B84","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drudis.2017.09.006","article-title":"Molecular targets and pathways for the treatment of visceral leishmaniasis","volume":"23","author":"Jain","year":"2018","journal-title":"Drug Discov. Today"},{"key":"B85","doi-asserted-by":"publisher","first-page":"12529","DOI":"10.3390\/ijms241512529","article-title":"Tackling sleeping sickness: current and promising therapeutics and treatment strategies","volume":"24","author":"Jamabo","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"828111","DOI":"10.3389\/fvets.2022.828111","article-title":"An update on African trypanocide pharmaceutics and resistance","volume":"9","author":"Kasozi","year":"2022","journal-title":"Front. Vet. Sci."},{"key":"B87","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","article-title":"Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)","volume":"12","author":"Kennedy","year":"2013","journal-title":"Lancet Neurol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1007\/s00415-019-09425-7","article-title":"Update on human African trypanosomiasis (sleeping sickness)","volume":"266","author":"Kennedy","year":"2019","journal-title":"J. Neurol."},{"key":"B89","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature19339","article-title":"Proteasome inhibition for treatment of leishmaniasis, chagas disease and sleeping sickness","volume":"537","author":"Khare","year":"2016","journal-title":"Nature"},{"key":"B90","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1186\/s13104-020-05077-3","article-title":"Prevalence of trypanosomes associated with drug resistance in shimba hills, Kwale county, Kenya","volume":"13","author":"Kulohoma","year":"2020","journal-title":"BMC Res. Notes"},{"key":"B91","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/trstmh\/traa160","article-title":"Disability, mental health, stigma and discrimination and neglected tropical diseases","volume":"115","author":"Kuper","year":"2021","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B92","doi-asserted-by":"publisher","first-page":"2350","DOI":"10.12688\/f1000research.9218.1","article-title":"Plasticity of the leishmania genome leading to gene copy number variations and drug resistance","volume":"5","author":"Laffitte","year":"2016","journal-title":"F1000Res"},{"key":"B93","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1093\/inthealth\/ihad043","article-title":"A year of one health and neglected tropical diseases","volume":"15","author":"Laing","year":"2023","journal-title":"Int. Health"},{"key":"B94","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/trstmh\/traa117","article-title":"One health for neglected tropical diseases","volume":"115","author":"Laing","year":"2021","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B95","unstructured":"The lancet series on one health and global health security\n          \n          \n          2023"},{"key":"B96","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/j.1365-294X.2007.03375.x","article-title":"Evolution of pathogens in a man-made world","volume":"17","author":"Lebarbenchon","year":"2008","journal-title":"Mol. Ecol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijpddr.2014.09.005","article-title":"Drug resistance analysis by next generation sequencing in leishmania","volume":"5","author":"Leprohon","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist"},{"key":"B98","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","article-title":"The science of antibiotic discovery","volume":"181","author":"Lewis","year":"2020","journal-title":"Cell"},{"key":"B99","doi-asserted-by":"publisher","first-page":"e2209476119","DOI":"10.1073\/pnas.2209476119","article-title":"Ancient pathogens provide a window into health and well-being","volume":"120","author":"Lewis","year":"2023","journal-title":"PNAS"},{"key":"B100","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/tmi.13915","article-title":"Oral transmission of chagas disease from a one health approach: a systematic review","volume":"28","author":"L\u00f3pez-Garc\u00eda","year":"2023","journal-title":"Trop. Med. Int. Health"},{"key":"B101","doi-asserted-by":"publisher","first-page":"e73488","DOI":"10.7554\/eLife.73488","article-title":"Stress conditions promote leishmania hybridization in vitro marked by expression of the ancestral gamete fusogen HAP2 as revealed by single-cell RNA-seq","volume":"11","author":"Louradour","year":"2022","journal-title":"Elife"},{"key":"B102","doi-asserted-by":"publisher","first-page":"e250","DOI":"10.1016\/S2666-5247(21)00028-8","article-title":"Leishmania donovani hybridisation and introgression in nature: a comparative genomic investigation","volume":"2","author":"Lypaczewski","year":"2021","journal-title":"Lancet Microbe"},{"key":"B103","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/tropicalmed5010042","article-title":"From colonial research spirit to global commitment: Bayer and African sleeping sickness in the mirror of history","volume":"5","author":"Madeja","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"B104","first-page":"19","article-title":"Historique du peuplement bovine et de l\u2019introduction de la tique Amblyomma variegatum dans la \u00eeles fran\u00e7aises des Antilles: synth\u00e8se bibliographique","volume":"61","author":"Maillard","year":"1998","journal-title":"Ethnozootech"},{"key":"B105","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1093\/trstmh\/trab002","article-title":"A road map for neglected tropical diseases 2021-2030","volume":"115","author":"Malecela","year":"2021","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B106","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/1087057114559907","article-title":"Novel therapeutic approaches for neglected infectious diseases","volume":"20","author":"Martin-Plaza","year":"2015","journal-title":"J. Biomol. Screen"},{"key":"B107","doi-asserted-by":"publisher","first-page":"e00113","DOI":"10.1016\/j.parepi.2019.e00113","article-title":"The elimination of Trypanosoma brucei gambiense. Challenges of reservoir hosts and transmission cycles: expect the unexpected","volume":"6","author":"Mehlitz","year":"2019","journal-title":"Parasite Epidemiol. Control"},{"key":"B108","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/infdis\/jis331","article-title":"Benznidazole-resistance in Trypanosoma cruzi is a readily acquired trait that can arise independently in a single population","volume":"206","author":"Mejia","year":"2012","journal-title":"J. Infect. Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"107872","DOI":"10.1016\/j.actatropica.2025.107872","article-title":"A systematic review on the prevalence and characteristics of canine visceral leishmaniasis in stray and owned dogs in Brazil","volume":"271","author":"Mendon\u00e7a","year":"2025","journal-title":"Acta Trop."},{"key":"B111","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1865-1682.2012.01314.x","article-title":"Molecular demonstration of Trypanosoma evansi and Trypanosoma lewisi DNA in wild rodents from Cambodia, Lao PDR and Thailand","volume":"60","author":"Milocco","year":"2013","journal-title":"Transbound. Emerg. Dis."},{"key":"B112","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/2229-5070.129142","article-title":"Drug resistance in leishmaniasis: newer developments","volume":"4","author":"Mohapatra","year":"2014","journal-title":"Trop. Parasitol."},{"key":"B113","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/pathogens13100835","article-title":"Molecular mechanisms of drug resistance in leishmania spp","volume":"13","author":"Moncada-Diaz","year":"2024","journal-title":"Pathogens"},{"key":"B114","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1093\/cid\/civ004","article-title":"Miltefosine for visceral and cutaneous leishmaniasis: drug characteristics and evidence-based treatment recommendations","volume":"60","author":"Monge-Maillo","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/157489111794407868","article-title":"Antileishmanial patents antileishmanial current drugs and relevant patents","volume":"6","author":"Monzote","year":"2011","journal-title":"Recent Pat Antiinfect Drug. Discov."},{"key":"B116","doi-asserted-by":"publisher","first-page":"15","DOI":"10.25259\/JMRI_3_2021","article-title":"Genome plasticity and its role in leishmania adaptation and drug resistance","volume":"5","author":"Moody","year":"2021","journal-title":"J. Med. Res. Innov."},{"key":"B117","doi-asserted-by":"publisher","first-page":"16159","DOI":"10.1021\/acs.jmedchem.1c01437","article-title":"DNDI-6148: a novel benzoxaborole preclinical candidate for the treatment of visceral leishmaniasis","volume":"64","author":"Mowbray","year":"2021","journal-title":"J. Med. Chem."},{"key":"B118","doi-asserted-by":"publisher","first-page":"e2954","DOI":"10.1371\/journal.pntd.0002954","article-title":"Performance of parasitological and molecular techniques for the diagnosis and surveillance of gambiense sleeping sickness","volume":"8","author":"Mumba Ngoyi","year":"2014","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B119","doi-asserted-by":"publisher","first-page":"10773","DOI":"10.1021\/acs.jmedchem.0c00499","article-title":"Discovery and characterization of clinical candidate LXE408 as a kinetoplastid-selective proteasome inhibitor for the treatment of leishmaniases","volume":"63","author":"Nagle","year":"2020","journal-title":"J. Med. Chem."},{"key":"B120","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1590\/0074-02760140285","article-title":"Update on oral chagas disease outbreaks in Venezuela: epidemiological, clinical and diagnostic approaches","volume":"110","author":"Noya","year":"2015","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"B121","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1136\/bmj.320.7244.1228","article-title":"Research does not reflect global disease burden","volume":"6","author":"O'Neale Roach","year":"2000","journal-title":"BMJ"},{"key":"B122","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/jme\/tjac018","article-title":"African animal trypanosomiasis: a systematic review on prevalence, risk factors and drug resistance in Sub-Saharan Africa","volume":"59","author":"Okello","year":"2022","journal-title":"J. Med Entomol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.3390\/microorganisms9122500","article-title":"Antileishmanial drug discovery and development: time to reset the model?","volume":"9","author":"Ol\u00edas-Molero","year":"2021","journal-title":"Microorganisms"},{"key":"B125","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/s0140-6736(17)31612-4","article-title":"Chagas disease","volume":"391","author":"P\u00e9rez-Molina","year":"2018","journal-title":"Lancet"},{"key":"B126","doi-asserted-by":"publisher","first-page":"687110","DOI":"10.3389\/fpubh.2021.687110","article-title":"From the approach to the concept: one health in Latin america-experiences and perspectives in Brazil, Chile, and Colombia","volume":"9","author":"Pettan-Brewer","year":"2021","journal-title":"Front. Public Health"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1039\/d1md00362c","article-title":"Current leishmaniasis drug discovery","volume":"13","author":"Pinheiro","year":"2022","journal-title":"RSC Med. Chem."},{"key":"B128","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1038\/nrd1824","article-title":"Opportunities and challenges in antiparasitic drug discovery","volume":"4","author":"Pink","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"B129","doi-asserted-by":"publisher","first-page":"e0006052","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-822794-7.00004-6","article-title":"Chapter 1 - an introduction to the concept of one health","author":"Prata","year":"2022","journal-title":"Teresa Rocpha-Santos One Health"},{"key":"B131","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/nrd1418","article-title":"Science, pharmacoeconomics and ethics in drug R&D: a sustainable future scenario?","volume":"3","author":"Preziosi","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"B132","doi-asserted-by":"publisher","first-page":"1227865","DOI":"10.3389\/fcimb.2023.1227865","article-title":"Editorial one health approach in zoonosis: strategies to control, diagnose and treat neglected diseases","volume":"13","author":"Quaresma","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"B133","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.ijpara.2006.06.019","article-title":"First report of genetic hybrids between two very divergent leishmania species: Leishmania infantum and Leishmania major","volume":"36","author":"Ravel","year":"2006","journal-title":"Int. J. Parasitol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2174\/1389202918666170911161311","article-title":"Gene and chromosomal copy number variations as an adaptive mechanism towards a parasitic lifestyle in trypanosomatids","volume":"19","author":"Reis-Cunha","year":"2018","journal-title":"Curr. Genomics"},{"key":"B135","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.pt.2021.04.007","article-title":"Pharma to farmer: field challenges of optimizing trypanocide use in African animal trypanosomiasis","volume":"37","author":"Richards","year":"2021","journal-title":"Trends Parasitol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"e1004092","DOI":"10.1371\/journal.pgen.1004092","article-title":"Genomic confirmation of hybridisation and recent inbreeding in a vector-isolated leishmania population","volume":"10","author":"Rogers","year":"2014","journal-title":"PLoS Genet."},{"key":"B137","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pt.2008.10.004","article-title":"How has agriculture influenced the geography and genetics of animal parasites?","volume":"25","author":"Rosenthal","year":"2009","journal-title":"Trends Parasitol."},{"key":"B141","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pt.2024.02.002","article-title":"A promising pipeline of preclinical drug candidates for leishmaniasis and chronic chagas' disease","volume":"40","author":"Saldivia","year":"2024","journal-title":"Trends Parasitol."},{"key":"B142","first-page":"181","article-title":"Chapter 8: recent advances in drug development for chagas disease: two magic words, combination and repositioning","volume-title":"Different aspects on chemotherapy of trypanosomatids","author":"Salom\u00e3o","year":"2017"},{"key":"B143","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2174\/092986710790226101","article-title":"Chagas disease: progress and new perspectives","volume":"17","author":"S\u00e1nchez-Sancho","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"B144","doi-asserted-by":"publisher","first-page":"e34039","DOI":"10.7554\/eLife.34039","article-title":"Spontaneous dormancy protects Trypanosoma cruzi during extended drug exposure","volume":"7","author":"S\u00e1nchez-Valdez","year":"2018","journal-title":"Elife"},{"key":"B145","doi-asserted-by":"publisher","first-page":"826287","DOI":"10.3389\/fcimb.2022.826287","article-title":"Impact of genetic diversity and genome plasticity of leishmania spp. in treatment and the search for novel chemotherapeutic targets","volume":"12","author":"Santi","year":"2022","journal-title":"Front. Cell Infect. Microbiol."},{"key":"B138","article-title":"Intellectual property as a determinant of health (October 6, 2020)","volume":"54","author":"Santos Rutschman","year":"2021","journal-title":"Vand. J. Transnat'l L"},{"key":"B147","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nrd3681","article-title":"Diagnosing the decline in pharmaceutical R&D efficiency","volume":"11","author":"Scannell","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"B148","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrd.2017.232","article-title":"Automating drug discovery","volume":"17","author":"Schneider","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"B149","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/ijms18061296","article-title":"Cutaneous manifestations of human and murine leishmaniasis","volume":"18","author":"Scorza","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B150","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s41231-019-0050-7","article-title":"Lost in translation: the valley of death across preclinical and clinical divide\u2014Identification of problems and overcoming obstacles","volume":"4","author":"Seyhan","year":"2019","journal-title":"Transl. Med. Commun."},{"key":"B151","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fpubh.2016.00260","article-title":"The human-nature relationship and its impact on health: a critical review","volume":"18","author":"Seymour","year":"2016","journal-title":"Front. Public Health"},{"key":"B152","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/s0035-9203(97)90413-2","article-title":"RAPD for the differentiation of leishmania","volume":"91","author":"Shaw","year":"1997","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"B153","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.3201\/eid3009.231238","article-title":"Autochthonous leishmaniasis caused by Leishmania tropica, identified by using whole-genome sequencing, Sri Lanka","volume":"30","author":"Silva","year":"2024","journal-title":"Emerg. Infect. Dis."},{"key":"B154","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1186\/s13071-015-1254-y","article-title":"Challenges facing the elimination of sleeping sickness in west and central Africa: sustainable control of animal trypanosomiasis as an indispensable approach to achieve the goal","volume":"8","author":"Simo","year":"2015","journal-title":"Parasites Vectors"},{"key":"B155","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/pathogens12050706","article-title":"Recent advances in chemotherapeutics for leishmaniasis: importance of the cellular biochemistry of the parasite and its molecular interaction with the host","volume":"12","author":"Singh","year":"2023","journal-title":"Pathogens"},{"key":"B156","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2174\/0115734099260187230921073932","article-title":"Automation of drug discovery through cutting-edge in-silico research in pharmaceuticals: challenges and future scope","volume":"20","author":"Singh","year":"2024","journal-title":"Curr. Comput. Aided Drug Des."},{"key":"B157","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1111\/1462-2920.15056","article-title":"Vesiduction: the fourth way of HGT","volume":"22","author":"Soler","year":"2020","journal-title":"Environ. Microbiol."},{"key":"B158","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/j.1365-2958.2012.08185.x","article-title":"Novel insights into genome plasticity in eukaryotes: Mosaic aneuploidy in leishmania","volume":"86","author":"Sterkers","year":"2012","journal-title":"Mol. Microbiol."},{"key":"B159","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.pt.2014.07.002","article-title":"Parasexuality and mosaic aneuploidy in leishmania: alternative genetics","volume":"30","author":"Sterkers","year":"2014","journal-title":"Trends Parasitol."},{"key":"B160","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1756-3305-1-3","article-title":"The history of African trypanosomiasis","volume":"1","author":"Steverding","year":"2008","journal-title":"Parasites Vectors"},{"key":"B161","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1756-3305-3-15","article-title":"The development of drugs for treatment of sleeping sickness: a historical review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasites Vectors"},{"key":"B162","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/1756-3305-7-317","article-title":"The history of chagas disease","volume":"7","author":"Steverding","year":"2014","journal-title":"Parasit. Vectors"},{"key":"B163","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasit. Vectors"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1080\/21505594.2020.1809963","article-title":"The spreading of parasites by human migratory activities","volume":"11","author":"Steverding","year":"2020","journal-title":"Virulence"},{"key":"B165","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/14728222.2018.1472241","article-title":"Emerging therapeutic targets for treatment of leishmaniasis","volume":"22","author":"Sundar","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"B166","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/21678707.2024.2335248","article-title":"Current and emerging therapies for the treatment of leishmaniasis","volume":"12","author":"Sundar","year":"2024","journal-title":"Expert Opin. Orphan Drugs"},{"key":"B167","volume-title":"Impacts of trypanosomiasis on African agriculture; PAAT technical and scientific series 2; food and agriculture","author":"Swallow","year":"2000"},{"key":"B168","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S1473-3099(17)30538-8","article-title":"Treatment of adult chronic indeterminate chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial","volume":"18","author":"Torrico","year":"2018","journal-title":"Lancet Infect. Dis."},{"key":"B169","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/S0140-6736(02)09096-7","article-title":"Drug development for neglected diseases: a deficient market and a public-health policy failure","volume":"359","author":"Trouiller","year":"2002","journal-title":"Lancet"},{"key":"B170","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1574-695X.2008.00455.x","article-title":"Leishmania: origin, evolution and future since the Precambrian","volume":"54","author":"Tuon","year":"2008","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"B171","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1186\/gb-2008-9-7-r115","article-title":"Modulation of gene expression in drug resistant leishmania is associated with gene amplification, gene deletion and chromosome aneuploidy","volume":"9","author":"Ubeda","year":"2008","journal-title":"Genome Biol."},{"key":"B172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apar.2021.08.007","article-title":"Towards global control of parasitic diseases in the Covid-19 era: one health and the future of multisectoral global health governance","volume":"114","author":"Ung","year":"2021","journal-title":"Adv. Parasitol."},{"key":"B200","year":"2023"},{"key":"B173","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1586\/14787210.2014.916614","article-title":"Treatment failure in leishmaniasis: drug-resistance or another (epi-) phenotype?","volume":"12","author":"Vanaerschot","year":"2014","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B174","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1093\/heapol\/czw144","article-title":"Support and performance improvement for primary health care workers in low- and middle-income countries: a scoping review of intervention design and methods","volume":"32","author":"Vasan","year":"2017","journal-title":"Health Policy Plan."},{"key":"B175","doi-asserted-by":"crossref","DOI":"10.1093\/acrefore\/9780199366439.013.436","article-title":"Animals in Latin American history","volume-title":"Oxford research encyclopedia of Latin American history","author":"Vergara","year":"2018"},{"key":"B176","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1128\/AAC.01662-13","article-title":"Latin American network for chagas disease, NHEPACHA. Towards a paradigm shift in the treatment of chronic chagas disease","volume":"58","author":"Viotti","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B177","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ijpara.2007.02.002","article-title":"Increased transmission potential of leishmania major\/leishmania infantum hybrids","volume":"37","author":"Volf","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s40249-018-0444-1","article-title":"Innovation in neglected tropical disease drug discovery and development","volume":"7","author":"Wenig","year":"2018","journal-title":"Infect. Dis. Poverty"},{"key":"B191","unstructured":"Leishmaniasis\n          \n          \n          2004"},{"key":"B180","doi-asserted-by":"publisher","first-page":"837460","DOI":"10.3389\/fitd.2022.837460","article-title":"Tackling drug resistance and other causes of treatment failure in leishmaniasis","volume":"3","author":"Wijnant","year":"2022","journal-title":"Front. Trop. Dis."},{"key":"B181","doi-asserted-by":"publisher","first-page":"5022","DOI":"10.1073\/pnas.0711014105","article-title":"A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes","volume":"105","author":"Wilkinson","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B182","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1136\/vr.g3678","article-title":"One health, many histories","volume":"174","author":"Woods","year":"2014","journal-title":"Vet. Rec."},{"key":"B183","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s10158-007-0055-1","article-title":"The challenges of developing novel antiparasitic drugs","volume":"7","author":"Woods","year":"2007","journal-title":"Invert. Neurosci."},{"key":"B184","doi-asserted-by":"publisher","first-page":"887","DOI":"10.4155\/fmc.11.39","article-title":"Discovery and development of veterinary antiparasitic drugs: past, present and future","volume":"3","author":"Woods","year":"2011","journal-title":"Future Med. Chem."},{"key":"B185","unstructured":"Road map for neglected tropical diseases 2021-2030\n          \n          \n          2020"},{"key":"B186","unstructured":"Ending the neglect to attain the sustainable development goals: a road map for neglected tropical diseases 2021\u20132030\n          \n          \n          2021"},{"key":"B187","unstructured":"Current world population\n          \n          \n          2025"},{"key":"B188","unstructured":"WVA policies: one health\n          \n          \n          2025"},{"key":"B189","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1073\/pnas.1820175116","article-title":"Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition","volume":"116","author":"Wyllie","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B190","doi-asserted-by":"publisher","first-page":"e0012735","DOI":"10.1371\/journal.pntd.0012735","article-title":"Progress in antileishmanial drugs: mechanisms, challenges, and prospects","volume":"19","author":"Zhang","year":"2025","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1815438\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:15:30Z","timestamp":1778840130000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fchem.2026.1815438\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,15]]},"references-count":192,"alternative-id":["10.3389\/fchem.2026.1815438"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2026.1815438","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,15]]},"article-number":"1815438"}}